SKG Pharma`s Rasagiline Mesylate Receives Approval In the US
Enforcement Report - Week of September 27, 2023
Enforcement Report - Week of January 25, 2023
Dr. Reddy`s Generics Rasagiline Mesylate Receives Approval in US
Indoco Remedies Generic Rasagiline Receives Approval in US
Indoco Remedies has received the final approval for its Abbreviated New Drug Application (ANDA) for Rasagiline 0.5 mg and 1 mg tablets from the United States Food & Drug Administration (USFDA).
Sandoz's Generic Rasagiline Mesylate Receives Approval in US
Alkem Lab’s Generic Rasagiline Mesylate Receives Approval In US
Mylan N.V. (NASDAQ, TASE: MYL) today announced the U.S. launch of Rasagiline Tablets, 0.5 mg and 1 mg, a generic version of the reference listed drug, Teva's Azilect® Tablets. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is indicated in the treatment of Parkinson's disease.
Mylan Pharm’s Generic Rasagiline Mesylate Receives Approval In US